Guangzhou, CN 

Overview

Xiaoling Lei practices practicing medicine in Guangzhou, China.

Their clinical expertise encompasses Ecthyma, Hairy Cell Leukemia (HCL), and H1N1 Influenza.

They are actively involved in clinical research, co-authoring 9 peer reviewed articles.

Locations

Guangzhou, 510642, China
Other Locations
Dalian, 116034, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Frequently Asked Questions about Xiaoling Lei

Is Xiaoling Lei a top-rated expert for Ecthyma?

MediFind is an objective health platform that identifies experts based on real-world data. Xiaoling Lei is classified as an Experienced expert for Ecthyma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xiaoling Lei participate in research or clinical trials?

Yes. Xiaoling Lei has published 9 articles and abstracts on conditions like Ecthyma. You can view a list of Xiaoling Lei's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lei's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile